Atlas Trials

Tolerance Through Mixed Chimerism (Sip-Tego)

Clinical trial NCT06972069 · RECRUITING

Trial details

NCT number
NCT06972069
Sponsor
Tatsuo Kawai, MD, PhD
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Kidney FailureTransplant Recipient (Kidney)Transplant ToleranceImmunosuppresionImmunosuppression After Kidney Transplantation
Start date
2025-05-31
Primary completion
2030-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.